CME Group Inc. (NASDAQ:CME) Shares Sold by M&G Plc

M&G PLC lowered its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 7.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 918,722 shares of the financial services provider's stock after selling 68,946 shares during the quarter. CME Group makes up 1.0% of M&G PLC's portfolio, making the stock its 18th biggest holding. M&G PLC owned approximately 0.26% of CME Group worth $203,038,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Capital International Investors lifted its position in shares of CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock worth $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. raised its holdings in shares of CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock worth $444,443,000 after acquiring an additional 1,309,097 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in shares of CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock valued at $126,872,000 after acquiring an additional 550,133 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock valued at $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Finally, International Assets Investment Management LLC increased its position in CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider's stock worth $1,072,070,000 after purchasing an additional 483,618 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of NASDAQ:CME traded up $0.87 during trading on Thursday, hitting $222.04. The stock had a trading volume of 1,908,330 shares, compared to its average volume of 1,918,805. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36. The stock has a market capitalization of $79.96 billion, a price-to-earnings ratio of 23.40, a price-to-earnings-growth ratio of 5.61 and a beta of 0.55. The stock has a 50-day simple moving average of $221.36 and a two-hundred day simple moving average of $209.75.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm's quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the firm posted $2.25 earnings per share. On average, equities research analysts expect that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.07%. CME Group's payout ratio is 48.37%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Piper Sandler upped their price objective on CME Group from $240.00 to $250.00 and gave the company an "overweight" rating in a research report on Monday, October 28th. Citigroup lifted their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a "buy" rating in a research note on Thursday, October 24th. The Goldman Sachs Group increased their target price on shares of CME Group from $195.00 to $198.00 and gave the company a "sell" rating in a research note on Thursday, October 3rd. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an "outperform" rating in a research note on Thursday, October 24th. Finally, Redburn Atlantic lowered shares of CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price objective on the stock. in a research report on Tuesday, October 8th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, CME Group has a consensus rating of "Hold" and a consensus price target of $222.73.

Insider Buying and Selling at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 4,500 shares of the company's stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the transaction, the insider now owns 27,053 shares of the company's stock, valued at approximately $6,131,291.92. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.